Prostate cancer (PCa) is the most common form of cancer in men from developed countries, and ranks second in cancer-related deaths. The rapid recurrence of drug-resistant tumors in patients with incurable androgen-independent castrate resistant prostate cancer (CRPC-AI) underscores the need for more effective therapies. Our recent findings suggest that androgen deprivation therapy (ADT) enriches for […]
Read More